Heart failure pharmacotherapy and supports in the elderly - A short review

Current Cardiology Reviews

Volumn 12, Issue 3, 2016, Pages 180-185

  Shakib, Sepehr ^a   Clark, Robyn A ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Cardiac; Comorbidity; Elderly; Heart failure; Pharmacotherapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIOVASCULAR RISK; COGNITIVE DEFECT; END STAGE RENAL DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTENSION; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TELEMONITORING;

EID: 84981537710     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X12666160622102802     Document Type: Article

References (53)

1. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med 2008; 168(4): 418-24.
2. de Giuli F, Khaw KT, Cowie MR, Sutton GC, Ferrari R, Poole-Wilson PA. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail 2005; 7(3): 295-302.
3. Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011; 10(4): 430-9.
4. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003; 362(9378): 147-58.
5. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62(16): e147-239.
6. Caughey GE, Roughead EE, Shakib S, Vitry AI, Gilbert AL. Comorbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data. Drugs Aging 2011; 28(7): 575-81.
7. Wong DT, Clark RA, Dundon BK, Philpott A, Molaee P, Shakib S. Caveat anicula! Beware of quiet little old ladies: demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function. Med J Aust 2010; 192(1): 9-13.
8. Liao L, Jollis JG, Anstrom KJ, et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 2006; 166(1): 112-8.
9. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14(8): 803-69.
10. van der Wel MC, Jansen RW, Bakx JC, Bor HH, Olderikkert MG, van Weel C. Non-cardiovascular co-morbidity in elderly patients with heart failure outnumbers cardiovascular co-morbidity. Eur J Heart Fail 2007; 9(6-7): 709-15.
11. Muzzarelli S, Leibundgut G, Maeder MT, et al. Predictors of early readmission or death in elderly patients with heart failure. Am Heart J 2010; 160(2): 308-14.
12. Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail 2010; 12(5): 508-15.
13. Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med 2011; 27(1): 1-15.
14. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146-56.
15. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 2001; 1: 323-36.
16. Franzen K, Saveman BI, Blomqvist K. Predictors for health related quality of life in persons 65 years or older with chronic heart failure. Eur J Cardiovasc Nurs 2007; 6(2): 112-20.
17. Buck HG, Riegel B. The impact of frailty on health related quality of life in heart failure. Eur J Cardiovasc Nurs 2011; 10(3): 159-66.
18. McNallan SM, Singh M, Chamberlain AM, et al. Frailty and healthcare utilization among patients with heart failure in the community. JACC Heart Fail 2013; 1(2): 135-41.
19. Mangoni AA. Predicting and detecting adverse drug reactions in old age: challenges and opportunities. Expert Opin Drug Metab Toxicol 2012; 8(5): 527-30.
20. Formiga F, Chivite D, Sole A, Manito N, Ramon JM, Pujol R. Functional outcomes of elderly patients after the first hospital admission for decompensated heart failure (HF). A prospective study. Arch Gerontol Geriatr 2006; 43(2): 175-85.
21. Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009; 119(4): 515-23.
22. Manzano L, Babalis D, Roughton M, et al. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail 2011; 13(5): 528-36.
23. Huynh BC, Rovner A, Rich MW. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial. Arch Intern Med 2006; 166(17): 1892-8.
24. Oudejans I, Mosterd A, Zuithoff NP, Hoes AW. Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients. J Card Fail 2012; 18(1): 47-52.
25. Delgado Parada E, Suarez Garcia FM, Lopez Gaona V, Gutierrez Vara S, Solano Jaurrieta JJ. Mortality and functional evolution at one year after hospital admission due to heart failure (HF) in elderly patients. Arch Gerontol Geriatr 2012; 54(1): 261-5.
26. Gastelurrutia P, Lupon J, Altimir S, et al. Fragility is a key determinant of survival in heart failure patients. Int J Cardiol 2014; 175(1): 62-6.
27. Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 2005; 35(12): 723-30.
28. Rickenbacher P, Pfisterer M, Burkard T, et al. Why and how do elderly patients with heart failure die? Insights from the TIMECHF study. Eur J Heart Fail 2012; 14(11): 1218-29.
29. Garg R, Yusuf S. Overview of randomized trials of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995; 273(18): 1450-6.
30. Dulin BR, Haas SJ, Abraham WT, Krum H. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials. Am J Cardiol 2005; 95(7): 896-8.
31. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 1999; 100(23): 2312-8.
32. Pfisterer M, Buser P, Rickli H, et al. BNP-guided vs symptomguided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009; 301(4): 383-92.
33. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359(23): 2456-67.
34. Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27(19): 2338-45.
35. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362(9386): 777-81.
36. Fu M, Zhou J, Sun A, et al. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies. Int J Cardiol 2012; 155(1): 33-8.
37. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europ. Part 2: treatment. Eur Heart J 2003; 24(5): 464-74.
38. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44(4): 810-9.
39. Pulignano G, Del Sindaco D, Di Lenarda A, et al. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med 2010; 11(10): 739-47.
40. Ho TH, Caughey GE, Shakib S. Guideline compliance in chronic heart failure patients with multiple comorbid diseases: evaluation of an individualised multidisciplinary model of care. PLoS One 2014; 9(4): e93129.
41. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330(7486): 293.
42. Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther 2007; 32(4): 343-52.
43. Roughead EE, Barratt JD, Ramsay E, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2(5): 424-8.
44. Lövgren S, Clark RA, Angley M, Ponniah AP, Colley D, Shakib S. Timeliness and clinical impact of hospital-initiated medication reviews. J Pharm Pract 2009; 39(4): 269-73.
45. Vitry AI, Nguyen TA, Ramsay EN, et al. General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure. Intern Med J 2014; 44(11): 1117-23.
46. Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010; 8(August 2010): 1-138.
47. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. Meta-Analysis of remote Monitoring of Heart Failure Patients J Am Coll Cardiol 2009; 54(18): 1683-94.
48. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011; 13(9): 1028-40.
49. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011; 378(9792): 731-9.
50. Cameron J, Ski CF, Thompson DR. Cognitive impairment in chronic heart failure and the need for screening. Am J Cardiol 2011; 107(10): 1547.
51. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162(15): 1682.
52. Clark RA, Yallop JJ, Piterman L, et al. Adherence, adaptation and acceptance of elderly chronic heart failure participants to receiving healthcare by telemonitoring. Eur J Heart Fail 2007; 9(11): 1104-11.
53. Guzman-Clark JRS, Servellen Gv, Chang B, Mentes J, Hahn TJ. Predictors and Outcomes of Early Adherence to the Use of a Home Telehealth Device by Older Veterans with Heart Failure. Telemed J E Health 2013; 19(3): 217-23.